Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
DNASE1 encodes a member of the DNase family. Zusätzlich bieten wir Ihnen Deoxyribonuclease I Kits (66) und Deoxyribonuclease I Proteine (31) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 94 products:
Human Polyclonal DNASE1 Primary Antibody für IHC, IHC (p) - ABIN4305666
Sonawane, Khanolkar, Namavari, Chaudhary, Gandhi, Tibrewal, Jassim, Shaheen, Hallak, Horner, Newcomb, Sarkar, Jain: Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease. in Investigative ophthalmology & visual science 2012
Genetic variants in DNase I hypersensitive sites play an important role in carcinogenesis. two novel single nucleotide polymorphisms rs12309362 (odds ratio = 0.64, P = 5.61 x 10(-6) ) and rs9970827 (odds ratio = 0.73, P = 7.23 x 10(-6) ) significantly associated with decreased risk of HCC (zeige FAM126A Antikörper).
Serum DNase1-activity is significantly decreased in ALD (zeige ABCD1 Antikörper) patients, indicating its potential implication in their pathogenesis. Furthermore, DNase1-activity could be used as a new surrogate biomarker for predicting response to AIH treatment.
Although no significant association between Q222R polymorphism in DNAse I gene and the risk of systemic lupus erythematosus was found, the presence of the A allele was associated with an increased risk for the development of nephropathy
DNase I activity was observed to be increased in type 2 diabetes, and high glucose combined with increased DNase I is suggested to aggravate beta-cell apoptosis.
Single nucleotide polymorphisms producing a loss-of-function variant of the enzymes in DNASE1, DNASE1L3 (zeige DNASE1L3 Antikörper), and DNASE2 (zeige DNASE2 Antikörper), possibly serving as a genetic risk factor for autoimmune diseases, were confirmed.
TNF-alpha (zeige TNF Antikörper) amplifies DNaseI expression in renal tubular cells while IL-1beta (zeige IL1B Antikörper) promotes nuclear DNaseI translocation in inactive form in lupus nephritis.
HumDN1 polymorphisms were examined in blood of 11 worldwide populations by polymerase chain reaction. 15 genotypes were found leading to the conclusion that HumDN1 variable no. tandem repeats are ethnic group specific.
Val66Met in the BDNF (zeige BDNF Antikörper) gene and two SNPs, Fokl and Apal, in the VDR (zeige CYP27B1 Antikörper) gene may potentially be associated with DED (zeige AATF Antikörper). Additionally, the association between DED (zeige AATF Antikörper) and Val66Met may vary by depression status.
In conclusion, elevated DNase I in diabetes may be related to pancreatic injury and could be one of the causes that induce diabetes.
Our results indicate that increased DNASE1 expression is common to both SLE and RA, while DNase1 reduction activity is specific to SLE.
DNase1 and DNase1-like 3 are independently expressed and thus provide dual host protection against deleterious effects of intravascular neutrophil extracellular traps.
HMGN1 (zeige HMGN1 Antikörper) binds to CpG island-containing promoters and affects the organization of nucleosomes, DNase I hypersensitivity, and the transcriptional profile of mouse embryonic stem cells and neural progenitors.
Early mesangial nephritis initiates a cascade of inflammatory signals that lead to up-regulation of Trap1 (zeige TRAP1 Antikörper) and a consequent down-regulation of renal DNaseI by transcriptional interference.
silencing of renal DNaseI gene expression initiates a cascade of inflammatory signals including activation of Toll (zeige TLR4 Antikörper) like receptors and Clec4e (zeige CLEC4E Antikörper), leading to progression of both murine and human lupus nephritis
Data show that deletion of DNaseI hypersensitive sites does not have an obvious impact on the IgH locus or B cell development.
Reduction in renal Dnase1 expression and activity is limited to mice and SLE patients with signs of membranoproliferative nephritis, and may be a critical event in the development of severe forms of lupus nephritis.
A conserved sequence located 211 kilobases upstream of class II major histocompatibility complex transcriptional coactivator (CIITA (zeige CIITA Antikörper)) promoter III is hypersensitive to DNase I.
The impact of antibodies to dsDNA, renal Dnase1 and matrix metalloprotease (MMP) mRNA levels and enzyme activities on early and late events in murine lupus nephritis, was determined.
serum Dnase1 in cooperation with the plasminogen (zeige PLG Antikörper) system guarantees a fast and effective breakdown of chromatin during necrosis by the combined cleavage of DNA as well as of DNA binding proteins.
DNase I is essential for kidney injury induced by cisplatin
ascorbic acid has the ability to inhibit DNase I, one of the main endonucleases involved in DNA fragmentation during apoptosis.
the practical capability of this assay system was successfully demonstrated by its use to determine DNase I activity in bovine urine.
Specificity in DNA-DNase I interaction is mediated by DNA flexibility, which influences the induced-fit transitions required to form productive complexes.
Purification and characterization of equine DNase 1 was done; it was confirmed to be of the parotid-type.
This gene encodes a member of the DNase family. This protein is stored in the zymogen granules of the nuclear envelope and functions by cleaving DNA in an endonucleolytic manner. At least six autosomal codominant alleles have been characterized, DNASE1*1 through DNASE1*6, and the sequence of DNASE1*2 represented in this record. Mutations in this gene have been associated with systemic lupus erythematosus (SLE), an autoimmune disease. A recombinant form of this protein is used to treat the one of the symptoms of cystic fibrosis by hydrolyzing the extracellular DNA in sputum and reducing its viscosity. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized.
, DNase I, lysosomal
, Dornase alfa
, human urine deoxyribonuclease I
, deoxyribonuclease I
, Deoxyribonuclease I